The DANish randomized, double-blind, placebo controlled trial in patients with chronic HEART failure (DANHEART): A 2 × 2 factorial trial of hydralazine-isosorbide dinitrate in patients with chronic heart failure (H-HeFT) and metformin in patients with chronic heart failure and diabetes or prediabetes (Met-HeFT)
Wiggers H.,
Køber L.,
Kristensen S.L.,
Møller J.,
Hassager C.,
Høfsten D.E.,
Gustafsson F.,
Gislason G.,
Schou M.,
Poulsen M.K.,
Vraa S.,
Nielsen O.W.,
Bruun N.E.,
Nørrelund H.,
Hollingdal M.,
Refsgaard J.,
Barasa A.,
Bøttcher M.,
Dodt K.,
Hansen V.B.,
Nielsen G.,
Knudsen A.S.,
Lomholdt J.,
Mikkelsen K.V.,
Jonczy B.,
Brønnum-Schou J.,
Poenaru M.P.,
Abdulla J.,
Raymond I.,
Mahboubi K.,
Sillesen K.,
Serup-Hansen K.,
Larsen A.H.,
Bøtker H.E.,
Eiskjær H.,
Mellemkjær S.,
Madsen J.S.,
Torp-Petersen C.,
Steffensen F.H.,
Bibby B.M.
Связанные документы (рекомендация CORE)
